Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use; D003906:Developing Countries; D004049:Diethylcarbamazine / Q000008:administration & dosage / Q000627:therapeutic use; D004196:Disease Outbreaks / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D004605:Elephantiasis, Filarial / Q000188:drug therapy / Q000453:epidemiology*; D005369:Filaricides / Q000008:administration & dosage / Q000627:therapeutic use; D014943:Global Health; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage / Q000627:therapeutic use; D015995:Prevalence; D018571:Sentinel Surveillance
D005369:Filaricides; D007559:Ivermectin; D015766:Albendazole; D004049:Diethylcarbamazine